Review Timeline | CrossMark Policy | ClinMed Features
logo
International Journal of
Neurology and Neurotherapy ISSN: 2378-3001

Citation

Wesnes KA, Reynolds J (2019) The Effects on the Cognitive Function of Healthy Volunteers of a Combination of Acetyl-L-Carnitine, Vinpocetine and Huperzine A Administered Over 28 Days. Int J Neurol Neurother 6:089. doi.org/10.23937/2378-3001/1410089

Copyright

© 2019 Wesnes KA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ORIGINAL ARTICLE | OPEN ACCESS DOI: 10.23937/2378-3001/1410089

The Effects on the Cognitive Function of Healthy Volunteers of a Combination of Acetyl-L-Carnitine, Vinpocetine and Huperzine A Administered Over 28 Days

Keith A Wesnes1,2,3* and Josh Reynolds4

1Wesnes Cognition Ltd, Little Paddock, Streatley Hill, Streatley on Thames, UK

2Visiting Professor, Department of Psychology, Northumbria University, Newcastle, UK

3Adjunct Professor, Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia

4MedHealth Direct, Laguna Beach, California, USA

Abstract

This report on a 4 week, randomized, placebo controlled, parallel group, repeated measures, double-blind study clinical trial of a preparation containing Acetyl-L-Carnitine, Vinpocetine and Huperzine A administered to healthy volunteers has identified that the product significantly improves a well validated global score from six tests of working and episodic memory, with an effect sized improvement comparable to the current medications approved to treat Alzheimer's disease.